Skip to main content
Top

Drugs

Issue 18/2009

Content (9 Articles)

Oseltamivir Resistance and the H274Y Neuraminidase Mutation in Seasonal, Pandemic and Highly Pathogenic Influenza Viruses

  • Current Opinion

Aeron C. Hurt, Jessica K. Holien, Michael W. Parker, Ian G. Barr

New Pharmacological Developments in the Treatment of Hepatocellular Cancer

  • Leading Article

Niraj J. Gusani, Yixing Jiang, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Hua Cheng, Jaffer A. Ajani

Treatment of Allergic Rhinitis in Infants and Children

  • Review Article

Hanna Phan, Matthew L. Moeller, Milap C. Nahata

Bacterial Meningitis

  • Review Article

Yuliya Nudelman, Allan R. Tunkel

Transdermal Granisetron

  • Adis Drug Profile

Sean T. Duggan, Monique P. Curran

Telavancin

  • Adis Drug Profile

Katherine A. Lyseng-Williamson, Stephanie K. A. Blick

Topical Diclofenac Solution

  • Adis Drug Profile

Marit D. Moen

Peginterferon-α-2a (40 kD)

  • Adis Drug Evaluation

Gillian M. Keating

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images